Cue Biopharma, Inc. (CUE) short interest & options flow
NASDAQCUE short interest collapsed 76% in one week to 0.25% of float, driven by a massive cover-off following the stock's 29% weekly decline. Cost to borrow soared to 224% as shorts scrambled to exit.
- Market cap
- $138M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026
Latest signals on CUE
- Short Interest
CUE short interest collapsed 76% in one week to 0.25% of float, driven by a massive cover-off following the stock's 29% weekly decline. Cost to borrow soared to 224% as shorts scrambled to exit.
- Utilization
CUE short interest utilization hits 100%, matching the 52-week peak, as shares to borrow remain fully deployed despite short interest falling 95% over the past month.
- Cost to Borrow
CUE cost to borrow explodes to 238% — up 126% in one week as shares become scarce to borrow.
CUE news and analysis
RSSNo long-form analysis yet for CUE. Pulse alerts and the live data picture are available on ORTEX.
Open CUE on ORTEX →Want the live picture for CUE?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CUE — free to start on ORTEX.
Sign up for free →Open CUE on ORTEX